A proteomic approach. Proteomics 2008, 8:1000-1008. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254. Bussone G, Dib H, Dimitrov JD, Camoin L, Broussard C, Tamas N, Guillevin L, Kaveri SV, Mouthon L: Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations. Proteomics 2009, 9:2253-2262. Guilpain P, Servettaz A, Tamby MC, Chanseaud Y, Tamas N, Garcia de la Pena-Lefebvre P, Broussard C, Guillevin L, Camoin L, Mouthon L: A combined SDS-PAGE and proteomics approach to identify target autoantigens in healthy individuals and patients with autoimmune diseases. Ann N Y Acad Sci 2007, 1109:538-549. ExPASy Proteomics Server. [http://www.expasy.org]. Ariadne Pathway Studio. [http://www.ariadnegenomics.com/products/ pathway-studio/]. Giusti L, Bazzichi L, Baldini C, Ciregia F, Mascia G, Giannaccini G, Del Rosso M, Bombardieri S, Lucacchini A: Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis. J Rheumatol 2007, 34:2063-2069. Terrier B, Tamby MC, Camoin L, Guilpain P, Berezne A, Tamas N, Broussard C, Hotellier F, Humbert M, Simonneau G, Guillevin L, Mouthon L: Antifibroblast antibodies from systemic sclerosis patients bind to enolase and are associated with interstitial lung disease. Ann Rheum Dis 2010, 69:428-433. Bussone G, Mouthon L: Interstitial lung disease in systemic sclerosis. Autoimmun Rev 2011, 10:248-255. Svegliati S, Cancello R, Sambo P, Luchetti M, Paroncini P, Orlandini G, Discepoli G, Paterno R, Santillo M, Cuozzo C, Cassano S, Avvedimento EV, Gabrielli A: Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1/ 2: amplification of ROS and Ras in systemic sclerosis fibroblasts. J Biol Chem 2005, 280:36474-36482. Dalpke AH, Thomssen R, Ritter K: Oxidative injury to endothelial cells due to Epstein-Barr virus-induced autoantibodies against manganese superoxide dismutase. J Med Virol 2003, 71:408-416. Scott JL, Gabrielides C, Davidson RK, Swingler TE, Clark IM, Wallis GA, BootHandford RP, Kirkwood TB, Taylor RW, Young DA: Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis 2010, 69:1502-1510. Lefranc D, Launay D, Dubucquoi S, de Seze J, Dussart P, Vermersch M, Hachulla E, Hatron PY, Vermersch P, Mouthon L, Prin L: Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach. Arthritis Rheum 2007, 56:3420-3432. Xiang Y, Sekine T, Nakamura H, Imajoh-Ohmi S, Fukuda H, Nishioka K, Kato T: Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis Rheum 2004, 50:1511-1521. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS: Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 2003, 423:293-298. McClintock D, Gordon LB, Djabali K: Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by Capecitabine an anti-Lamin A G608G antibody. Proc Natl Acad Sci PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/7500280 USA 2006, 103:2154-2159. Reeves WH, Chaudhary N, Salerno A, Blobel G: Lamin B autoantibodie.